Search

Your search keyword '"AstraZeneca PLC -- Officials and employees"' showing total 1,457 results
Start Over Descriptor "AstraZeneca PLC -- Officials and employees"
1,457 results on '"AstraZeneca PLC -- Officials and employees"'

1. Biogen appoints Minor, Pangalos as new independent directors

Subjects
AstraZeneca PLC -- Officials and employees, Biological products industry -- Officials and employees, Executives -- Appointments, resignations and dismissals, Pharmaceutical industry -- Officials and employees, Business, News, opinion and commentary
Abstract

The Biogen Board of Directors announced the appointments of two new independent directors, Lloyd B. Minor, M.D., effective October 1, 2024, and Sir Menela Pangalos, Ph.D., effective January 1, 2025. [...]

Published
2024

2. AstraZeneca PLC at OTC Deutsche Bank ADR Investor Conference (Virtual) - Final

Subjects
Deutsche Bank AG (Frankfurt, Germany) -- Officials and employees, AstraZeneca PLC -- Officials and employees, Banks (Finance), Biological products, Banking industry -- Officials and employees, Pharmaceutical industry -- Officials and employees, Banking industry, Business
Abstract

Presentation ZAFAR AZIZ, MODERATOR, DEUTSCHE BANK: Hello, and welcome to the Deutsche Bank Deposit Receipts Virtual Investor Conference. My name is Zafar Aziz from the Deutsche Bank team. I'm pleased [...]

Published
2024

3. SpyBiotech Names Dr. Prakash Bhuyan as Chief Medical Officer

Subjects
AstraZeneca PLC -- Officials and employees, Biological products industry -- Officials and employees, Communicable diseases, Chronic diseases, Vaccines, Pharmaceutical industry -- Officials and employees, Arts and entertainment industries
Abstract

SpyBiotech, a biotechnology company with a novel vaccine platform technology that can target infectious diseases, cancer, and chronic diseases, has appointed Dr. Prakash Bhuyan as Chief Medical Officer. The company [...]

Published
2024

4. Jazz Pharmaceuticals promotes Samantha Pearce to Chief Commercial Officer

Subjects
E.I. du Pont de Nemours and Co. DuPont Pharmaceuticals -- Officials and employees, AstraZeneca PLC -- Officials and employees, Celgene Corp. -- Officials and employees, Pharmaceutical industry -- Officials and employees, Business, News, opinion and commentary
Abstract

Jazz Pharmaceuticals announced that Samantha Pearce, SVP, Europe and International, has been promoted to Chief Commercial Officer effective August 1, 2024. Pearce joined Jazz as SVP, Europe and International, in [...]

Published
2024

5. Q2 2024 Ionis Pharmaceuticals Inc Earnings Call - Final

Subjects
Novartis AG -- Officials and employees, AstraZeneca PLC -- Officials and employees, Ionis Pharmaceuticals, Inc. -- Officials and employees, Pharmaceutical industry -- Officials and employees, Business, Wainua (Medication)
Abstract

Presentation OPERATOR: Good morning, and welcome to the Ionis second-quarter 2024 financial results conference call. As a reminder, this call is being recorded. At this time, I would like to [...]

Published
2024

6. AIM ImmunoTech Inc at JTC Team Virtual Investor Pitch Conference - Final

Subjects
Merck & Company Inc. -- Officials and employees, AstraZeneca PLC -- Officials and employees, Pharmaceutical industry -- Officials and employees, Business, Ampligen (Medication)
Abstract

Presentation JENENE THOMAS, MODERATOR, JTC IR: Okay. We are ready to get started. So good afternoon, and welcome back on day one of the Virtual Investor 2024 Pitch Conference. My [...]

Published
2024

7. Ionis Pharmaceuticals Inc Annual Shareholders Meeting - Final

Subjects
AstraZeneca PLC -- Officials and employees, Ionis Pharmaceuticals, Inc. -- Officials and employees, Adalimumab, Stockholders, Pharmaceutical industry -- Officials and employees, Business
Abstract

Presentation BRETT MONIA, CHIEF EXECUTIVE OFFICER, DIRECTOR, IONIS PHARMACEUTICALS INC: Good afternoon. Welcome, everybody, to the 2024 Annual Shareholders Meeting corporate update for Ionis Pharmaceuticals. My name is Brett Monia, [...]

Published
2024

8. AIM ImmunoTech Inc At Virtual Investor Lunch Break - Final

Subjects
AstraZeneca PLC -- Officials and employees, Pharmaceutical industry -- Officials and employees, Business, Ampligen (Medication), Keytruda (Medication)
Abstract

Presentation JENENE THOMAS, IR CONTACT OFFICER, AIM IMMUNOTECH INC: Good afternoon, everyone, and thank you for joining us for another Virtual Investor Lunch Break segment featuring AIM ImmunoTech. My name [...]

Published
2024

9. Checkpoint Therapeutics appoints Sharma to board of directors

Subjects
AstraZeneca PLC -- Officials and employees, Boards of directors -- Appointments, resignations and dismissals, Pharmaceutical industry -- Officials and employees, Business, News, opinion and commentary
Abstract

Checkpoint Therapeutics (CKPT) announced the appointment of Amit Sharma, M.D., FACP, FASN, FNKF, to its Board as an independent, non-executive director, effective immediately. Dr. Sharma currently serves as Vice President [...]

Published
2024

10. ASA MANELIUS NAMED MANAGING DIRECTOR OF NOVAVAX AB SITE

Subjects
Biora AB -- Officials and employees, Novavax Inc. -- Officials and employees, AstraZeneca PLC -- Officials and employees, Vaccines, News, opinion and commentary
Abstract

GAITHERSBURG, Md. -- The following information was released by Novavax, Inc.: Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M(TM) adjuvant, today announced that Åsa Manelius, [...]

Published
2024

11. Prescient Healthcare Group Names New CEO

Subjects
AstraZeneca PLC -- Officials and employees, Health care industry -- Officials and employees, Pharmaceutical industry -- Officials and employees, Health care industry, Business, News, opinion and commentary
Abstract

Prescient Healthcare Group Appoints Jason McKenna as New CEO LONDON, Oct. 17, 2024 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=4280016-1&h=3611853260&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4274823-1%26h%3D3756893989%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D3865725-1%2526h%253D1104104830%2526u%253Dhttp%25253A%25252F%25252Fwww.prescienthg.com%25252F%2526a%253DPrescient%252BHealthcare%252BGroup%26a%3DPrescient%2BHealthcare%2BGroup&a=Prescient+Healthcare+Group, a leading biopharma product and portfolio strategy firm, today announced the appointment of Jason [...]

Published
2024

12. Biogen Board Appoints Two New Independent Directors

Subjects
Biogen Inc. -- Officials and employees, AstraZeneca PLC -- Officials and employees, Biological products industry -- Officials and employees, Medical colleges, Pharmaceutical industry -- Officials and employees, General interest, News, opinion and commentary
Abstract

CAMBRIDGE: The Biogen Inc. announces the appointments of two new independent directors, Lloyd B. Minor, M.D., effective October 1, 2024, and Sir Menelas Pangalos, Ph.D., effective January 1, 2025. Dr. [...]

Published
2024

13. Biogen Board Appoints Two New Independent Directors

Subjects
Biogen Inc. -- Officials and employees, AstraZeneca PLC -- Officials and employees, Biological products industry -- Officials and employees, Medical colleges, Pharmaceutical industry -- Officials and employees, Business, international
Abstract

(GLOBE NEWSWIRE via COMTEX) -- Dr. Lloyd Minor and Prof Sir Menelas Pangalos bring significant scientific expertise and considerable experience in medicine research and development CAMBRIDGE, Mass., Sept. 12, 2024 [...]

Published
2024

14. Q1 2024 Ionis Pharmaceuticals Inc Earnings Call - Final

Subjects
AstraZeneca PLC -- Officials and employees, Ionis Pharmaceuticals, Inc. -- Officials and employees, Pharmaceutical industry -- Officials and employees, Business, Wainua (Medication)
Abstract

Presentation OPERATOR: Good morning, and welcome to Ionis' First Quarter 2024 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to [...]

Published
2024

15. IPS Elects Gordon Nicholson as Regional Director to Lead New Australian Office

Subjects
AstraZeneca PLC -- Officials and employees, Sanofi S.A. -- Officials and employees, Pharmaceutical industry -- Officials and employees, Arts and entertainment industries
Abstract

IPS-Integrated Project Services reporyted the appointment of Gordon Nicholson as the Regional Director, ANZ (Australia, New Zealand), to lead IPS' new Melbourne, Australia office. According to a media release, throughout [...]

Published
2024

16. IPS Elects Gordon Nicholson as Regional Director to Lead New Australian Office

Subjects
AstraZeneca PLC -- Officials and employees, Sanofi S.A. -- Officials and employees, Pharmaceutical industry -- Officials and employees, Arts and entertainment industries
Abstract

IPS-Integrated Project Services reporyted the appointment of Gordon Nicholson as the Regional Director, ANZ (Australia, New Zealand), to lead IPS' new Melbourne, Australia office. According to a media release, throughout [...]

Published
2024

17. Prescient Healthcare Group Names New CEO

Subjects
AstraZeneca PLC -- Officials and employees, Health care industry -- Officials and employees, Pharmaceutical industry -- Officials and employees, Health care industry, Advertising, marketing and public relations
Abstract

2024 NOV 9 (VerticalNews) -- By a News Reporter-Staff News Editor at Marketing Weekly News -- Prescient Healthcare Group, a leading biopharma product and portfolio strategy firm, announced the appointment [...]

Published
2024

18. DELFI Diagnostics Appoints Thomas Russo as Chief Financial Officer

Subjects
AstraZeneca PLC -- Officials and employees, Going public (Securities), Pharmaceutical industry -- Officials and employees, Company public offering, General interest, News, opinion and commentary
Abstract

BALTIMORE: DELFI Diagnostics has issued the following news release: Today, DELFI Diagnostics, Inc., developer of accessible blood-based liquid biopsy tests that deliver a new way to enhance early cancer detection, [...]

Published
2024

19. RED.Health appoints Prashant Agarwal as VP to transform 250+ hospital emergency services across India

Subjects
AstraZeneca PLC -- Officials and employees, Sanofi S.A. -- Officials and employees, Executives -- Appointments, resignations and dismissals, Hospitals -- Emergency service, Pharmaceutical industry -- Officials and employees, Biotechnology industry
Abstract

To ensure broader adoption and deeper integration of RED technologies and services Hyderabad-based startup RED.Health, a medical emergency response platform, has announced the appointment of Prashant Agarwal as Vice President [...]

Published
2024

20. Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors

Subjects
AstraZeneca PLC -- Officials and employees, Eli Lilly and Co. -- Officials and employees, Corporate directors -- Appointments, resignations and dismissals, Medical colleges, International business enterprises, Boards of directors -- Appointments, resignations and dismissals, Business, Business, international
Abstract

Prominent pharmaceutical leader from AstraZeneca, Abbott, GlaxoSmithKline and Eli Lilly, brings extensive regulatory affairs and clinical development expertise to Seaport Board BOSTON -- Seaport Therapeutics, a clinical-stage biopharmaceutical company that [...]

Published
2024

21. PureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors

Subjects
AstraZeneca PLC -- Officials and employees, Eli Lilly and Co. -- Officials and employees, Medical colleges, International business enterprises, Business, Business, international
Abstract

Prominent pharmaceutical leader from AstraZeneca, Abbott, GlaxoSmithKline and Eli Lilly, brings extensive regulatory affairs and clinical development expertise to Seaport Board BOSTON -- PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) [...]

Published
2024

22. FORM 8-K: CONDUIT PHARMACEUTICALS INC. Files Current Report (Aug 08, 2024)

Subjects
United States. Securities and Exchange Commission -- Officials and employees, AstraZeneca PLC -- Officials and employees, Securities law -- Reports, Stock-exchange -- Reports, Financial statements -- Reports, News, opinion and commentary, Securities Exchange Act
Abstract

Washington: CONDUIT PHARMACEUTICALS INC., has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Aug 08, 2024: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 [...]

Published
2024

23. SpyBiotech Appoints Dr. Prakash Bhuyan as Chief Medical Officer

Subjects
AstraZeneca PLC -- Officials and employees, Biological products industry -- Officials and employees, Communicable diseases, Chronic diseases, Pharmaceutical industry -- Officials and employees, Business, Business, international, University of Oxford -- Officials and employees
Abstract

OXFORD, England & CAMBRIDGE, Mass. -- SpyBiotech, a biotechnology company with a novel vaccine platform technology that can target infectious diseases, cancer, and chronic diseases, has appointed Dr. Prakash Bhuyan [...]

Published
2024

24. GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board

Subjects
AstraZeneca PLC -- Officials and employees, Marburg virus disease, Biological products industry -- Officials and employees, Pharmaceutical industry -- Officials and employees, Business, international
Abstract

Atlanta: GeoVax Labs, Inc. (GOVX) has issued the following press release: GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced [...]

Published
2024

25. GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board

Subjects
AstraZeneca PLC -- Officials and employees, Biological products industry -- Officials and employees, Pharmaceutical industry -- Officials and employees, Banking, finance and accounting industries, Business
Abstract

Strategic Appointment Enhances GeoVax's Leadership and Expertise in Vaccine Development ATLANTA, GA, Aug. 08, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines [...]

Published
2024

26. myTomorrows Appoints AstraZeneca Executive Vice President Iskra Reic to its Board of Directors

Subjects
AstraZeneca PLC -- Officials and employees, Boards of directors, Pharmaceutical industry -- Officials and employees, Business, News, opinion and commentary
Abstract

Reic, who leads AstraZeneca's global Vaccines & Immune Therapies unit, will play a key advisory role as myTomorrows furthers its mission of broadening access to clinical trials and expanded access [...]

Published
2024

27. SpringWorks Therapeutics Appoints Dr. Martin Mackay To Its Board of Directors

Subjects
AstraZeneca PLC -- Officials and employees, Corporate directors -- Appointments, resignations and dismissals, Chairpersons -- Appointments, resignations and dismissals, Boards of directors -- Appointments, resignations and dismissals, Pharmaceutical industry -- Officials and employees, General interest, News, opinion and commentary
Abstract

STAMFORD: SpringWorks Therapeutics, Inc., announces the appointment of Martin Mackay, Ph.D. to the Company's Board of Directors. Dr. Mackay is a highly accomplished research and development (R&D) executive with more [...]

Published
2024

28. SpringWorks Therapeutics Appoints Dr. Martin Mackay to its Board of Directors

Subjects
AstraZeneca PLC -- Officials and employees, Corporate directors, Pharmaceutical industry -- Officials and employees, Banking, finance and accounting industries, Business
Abstract

STAMFORD, Conn., July 29, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced the appointment of Martin [...]

Published
2024

29. Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch

Subjects
AstraZeneca PLC -- Officials and employees, Ipilimumab, Gene therapy, Business, News, opinion and commentary
Abstract

-- Company strengthens focus on building and optimizing commercial readiness and pre-launch activities for PRGN-2012 in recurrent respiratory papillomatosis -- GERMANTOWN, Md., July 23, 2024 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=4217125-1&h=2601758121&u=https%3A%2F%2Fprecigen.com%2F&a=Precigen%2C+Inc.(Nasdaq: PGEN), a [...]

Published
2024

30. Industry Veteran Ben Dudley Joins MMS As CCO To Drive Continued Growth for the Data-focused Clinical Research Organization

Subjects
AstraZeneca PLC -- Officials and employees, Medical research, Medicine, Experimental, Clinical trials, MMS (Multimedia messaging service), Pharmaceutical industry -- Officials and employees, General interest, News, opinion and commentary
Abstract

CANTON: MMS, announces that Ben Dudley has been appointed as the company's new Chief Commercial Officer (CCO). Based in the UK, Ben Dudley brings more than 25 years of life [...]

Published
2024

31. Industry Veteran Ben Dudley Joins MMS as Chief Commercial Officer (CCO) to Drive Continued Growth for the Data-focused Clinical Research Organization

Subjects
AstraZeneca PLC -- Officials and employees, Medical research, Medicine, Experimental, Biometry, Clinical trials, MMS (Multimedia messaging service), Pharmaceutical industry -- Officials and employees, News, opinion and commentary
Abstract

CANTON, Mich. & READING, England--(BUSINESS WIRE)--Jul 17, 2024-- MMS, a data-focused clinical research organization (CRO), announced today that Ben Dudley has been appointed as the company’s new Chief Commercial Officer [...]

Published
2024

32. I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer

Subjects
AstraZeneca PLC -- Officials and employees, Sanofi S.A. -- Officials and employees, Pharmaceutical industry -- Officials and employees, Business, News, opinion and commentary
Abstract

ROCKVILLE, Md., June 6, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the 'Company'), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for [...]

Published
2024

33. Verve Therapeutics Declares Leadership Update

Subjects
AstraZeneca PLC -- Officials and employees, Pharmaceutical industry -- Officials and employees, General interest, News, opinion and commentary
Abstract

BOSTON: Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, announced that Troy Lister, Ph.D., currently serving as [...]

Published
2024

34. Pandemic treaty allows WHO to seize a fifth of British vaccines. 'Arbitrary' WHO treaty will force UK to give away jabs

Subjects
AstraZeneca PLC -- Officials and employees, Epidemics -- United Kingdom, Vaccination, Public health, Vaccines, Pharmaceutical industry -- Officials and employees, General interest
Abstract

Byline: Joe Pinkstone and Sarah Knapton THE World Health Organisation (WHO) will have the power to demand that Britain hand over 20 per cent of its vaccines and drugs in [...]

Published
2024

35. How Big Pharma is fighting Biden's program to lower seniors' drug costs

Subjects
AstraZeneca PLC -- Officials and employees, Pricing -- Economic aspects, Drugs -- Prescribing, Pharmaceutical industry -- Officials and employees, Company business planning, Product price, Business, Computers and office automation industries, Telecommunications industry
Abstract

Byline: Tony Romm TRENTON, N.J. -- Pharmaceutical giants are mounting a vigorous legal battle against President Biden's plan to lower seniors' prescription drug costs, urging federal judges here and around [...]

Published
2024

36. How Big Pharma is fighting Bidenâs program to lower seniorsâ drug costs

Author

Romm, Tony

Subjects
AstraZeneca PLC -- Officials and employees, Pricing -- Economic aspects, Drugs -- Prescribing, Pharmaceutical industry -- Officials and employees, Company business planning, Product price, General interest, News, opinion and commentary
Abstract

Byline: Tony Romm TRENTON, N.J. - Pharmaceutical giants are mounting a vigorous legal battle against President Bidenâs plan to lower seniorsâ prescription drug costs, urging federal judges here and around [...]

Published
2024

37. Daiichi Sankyo Co Ltd ESG Briefing - Final

Subjects
Daiichi Sankyo Company Ltd. -- Officials and employees, AstraZeneca PLC -- Officials and employees, Business plans, Business planning, Pharmaceutical industry -- Officials and employees, Business, Enhertu (Medication)
Abstract

Presentation SUNAO MANABE, GROUP CEO & EXECUTIVE CHAIRPERSON, DAIICHI SANKYO COMPANY, LIMITED: Manabe speaking Thank you very much for joining Daiichi Sankyo's third year ESG briefing out of a very [...]

Published
2024

38. Full Year 2023 C4X Discovery Holdings PLC Earnings Call - Final

Subjects
AstraZeneca PLC -- Officials and employees, Chairpersons, Pharmaceutical industry -- Officials and employees, Business
Abstract

Presentation OPERATOR: Good day, ladies and gentlemen, and welcome to C4X Discovery Holdings plc full year results. (Operator Instructions) I would like to remind all participants that this call is [...]

Published
2023

39. Full Year 2023 C4X Discovery Holdings PLC Earnings Call - Final

Subjects
AstraZeneca PLC -- Officials and employees, Chairpersons, Pharmaceutical industry -- Officials and employees, Business
Abstract

Presentation OPERATOR: Good day, ladies and gentlemen, and welcome to C4X Discovery Holdings plc full year results. (Operator Instructions) I would like to remind all participants that this call is [...]

Published
2023

40. Caris Life Sciences names new director

Subjects
AstraZeneca PLC -- Officials and employees, Executives -- Appointments, resignations and dismissals, Pharmaceutical industry -- Officials and employees, Chemistry
Abstract

M2 PHARMA-August 26, 2024-Caris Life Sciences names new director (C)2024 M2 COMMUNICATIONS Caris Life Sciences, a next-generation AI TechBio company and precision medicine specialist, announced on Friday the appointment of [...]

Published
2024

41. Caris Life Sciences names new director

Subjects
AstraZeneca PLC -- Officials and employees, Executives -- Appointments, resignations and dismissals, Pharmaceutical industry -- Officials and employees, Business
Abstract

M2 EQUITYBITES-August 26, 2024-Caris Life Sciences names new director (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk Caris Life Sciences, a next-generation AI TechBio company and precision medicine specialist, announced on Friday the appointment [...]

Published
2024

42. SpyBiotech Appoints Dr. Prakash Bhuyan as Chief Medical Officer

Subjects
AstraZeneca PLC -- Officials and employees, Biological products industry -- Officials and employees, Communicable diseases, Chronic diseases, Pharmaceutical industry -- Officials and employees, Business, Business, international, Telecommunications industry
Abstract

SpyBiotech, a biotechnology company with a novel vaccine platform technology that can target infectious diseases, cancer, and chronic diseases, has appointed Dr. Prakash Bhuyan as Chief Medical Officer. The company [...]

Published
2024

43. myTomorrows names new director

Subjects
AstraZeneca PLC -- Officials and employees, Vaccines, Pharmaceutical industry -- Officials and employees, Chemistry
Abstract

M2 PHARMA-August 1, 2024-myTomorrows names new director (C)2024 M2 COMMUNICATIONS Netherlands-based global health technology company myTomorrows announced on Wednesday that it has named Iskra Reic, as its new independent director, [...]

Published
2024

44. myTomorrows names new director

Subjects
AstraZeneca PLC -- Officials and employees, Vaccines, Pharmaceutical industry -- Officials and employees, Business
Abstract

M2 EQUITYBITES-August 1, 2024-myTomorrows names new director (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk Netherlands-based global health technology company myTomorrows announced on Wednesday that it has named Iskra Reic, as its new independent [...]

Published
2024

45. LATEST COMPANY NEWS

Subjects
United States. Food and Drug Administration -- Officials and employees, GSK PLC -- Officials and employees, Pfizer Inc. -- Officials and employees, Roche Holding (UK) Ltd. -- Officials and employees, AstraZeneca PLC -- Officials and employees, Eisai Company Ltd. -- Officials and employees, Health care reform, Medical research, Medicine, Experimental, Genomics, Dapagliflozin, Cancer -- Genetic aspects, Lung cancer, Non-small cell -- Care and treatment, Type 2 diabetes -- Care and treatment, Pharmaceutical industry -- Officials and employees, Business, international, Association of the British Pharmaceutical Industry -- Officials and employees, European Union -- Officials and employees, Farxiga (Medication), Columvi (Medication)
Abstract

Pharmaceutical Times - Royal Marsden launches first UK genome testing facility to improve testing for cancer - 14/6/2024 The Royal Marsden NHS Foundation Trust has launched the UK's first ever [...]

Published
2024

46. I-Mab names new chief medical officer

Subjects
AstraZeneca PLC -- Officials and employees, Sanofi S.A. -- Officials and employees, Pharmaceutical industry -- Officials and employees, Chemistry
Abstract

M2 PHARMA-June 7, 2024-I-Mab names new chief medical officer (C)2024 M2 COMMUNICATIONS I-Mab (NASDAQ: IMAB), a US-based, global biotech company, announced on Thursday that it has named Dr Phillip Dennis [...]

Published
2024

47. I-Mab names new chief medical officer

Subjects
AstraZeneca PLC -- Officials and employees, Sanofi S.A. -- Officials and employees, Pharmaceutical industry -- Officials and employees, Business
Abstract

M2 EQUITYBITES-June 7, 2024-I-Mab names new chief medical officer (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk I-Mab (NASDAQ: IMAB), a US-based, global biotech company, announced on Thursday that it has named Dr Phillip [...]

Published
2024

48. Venatorx Pharmaceuticals Unveils Changes to Executive Leadership

Subjects
Pfizer Inc. -- Officials and employees, Entasis Therapeutics Holdings Inc. -- Officials and employees, AstraZeneca PLC -- Officials and employees, Biotechnology industry -- Officials and employees, Pharmaceutical industry -- Officials and employees, General interest, News, opinion and commentary
Abstract

MALVERN: Venatorx Pharmaceuticals, announces several changes to its executive leadership team. Manos Perros, PhD, has been appointed as Executive Chairman of the Board of Directors of Venatorx Pharmaceuticals. With over [...]

Published
2024

49. AstraZeneca withdraws sales of Covid-19 vaccine globally

Subjects
AstraZeneca PLC -- Officials and employees, Pharmaceutical industry -- Officials and employees, News, opinion and commentary, Regional focus/area studies, Covishield (Vaccine)
Abstract

WEB DESK, May 8 -- AstraZeneca has initiated the worldwide withdrawal of its Covid-19 vaccine due to a 'surplus of available updated vaccines' since the pandemic. According to a news [...]

Published
2024

50. Cellectis Welcomes Arthur Stril as Interim Chief Financial Officer

Subjects
AstraZeneca PLC -- Officials and employees, Chief financial officers, Pharmaceutical industry -- Officials and employees, General interest, News, opinion and commentary
Abstract

NEW YORK: Cellectis, a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced the resignation of Mr. Bing Wang from his position at [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results